Navigation Links
Questcor Reports Third Quarter Financial Results
Date:10/29/2013

and market introduction of competitive products;
  • Our ability to continue to generate revenue from sales of Acthar to treat on-label indications associated with NS, MS, IS or rheumatology-related conditions, and our ability to develop other therapeutic uses for Acthar;
  • Research and development risks, including risks associated with Questcor's work in the area of NS and Lupus, efforts to develop and obtain FDA approval of Synacthen, our reliance on third-parties to conduct research and development, and the ability of research and development to generate successful results;
  • The results of any pending or future litigation, investigations or claims, including government investigations and private securities litigation;
  • Our ability to comply with federal and state regulations, including regulations relating to pharmaceutical sales and marketing practices;
  • Regulatory changes or other policy actions by governmental authorities and other third parties in connection with U.S. health care reform or efforts to reduce federal and state government deficits;
  • An increase in the proportion of our Acthar unit sales comprised of Medicaid-eligible patients and government entities;
  • Our ability to estimate reserves required for Acthar used by government entities and Medicaid-eligible patients and the impact that unforeseen invoicing of historical Medicaid prescriptions may have upon our results;
  • Our ability to effectively manage our growth, including the expansion of our sales forces, planned international expansion, and our reliance on key personnel;
  • Our ability to integrate the BioVectra business with our business and to manage, and grow, a contract manufacturing business;
  • Our ability to comply with foreign regulations related to the operation of BioVectra's business and the international sales of Synacthen;
  • The impact to our business caused by economic conditions;
  • O
    '/>"/>

  • SOURCE Questcor Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related medicine technology :

    1. Questcor Pharmaceuticals to Present at JMP Securities Healthcare Conference
    2. Questcor to Report Second Quarter Results on July 24, 2012
    3. Questcor Reports Second Quarter Financial Results
    4. Questcor Pharmaceuticals to Present at Investor Conferences in September
    5. Questcor and The Myositis Association Team Up To Support Research and Educational Initiatives in Polymyositis and Dermatomyositis
    6. Questcor Comments on Insurance Policy Bulletin
    7. Questcor to Conduct Conference Call to Discuss Reimbursement Process
    8. Harwood Feffer LLP Announces Investigation of Questcor Pharmaceuticals, Inc.
    9. Questcor Pharmaceuticals Accelerates Cash Dividend; Payment Date Set for December 21, 2012
    10. Questcor Pharmaceuticals Appoints Michael Aldridge to the Position of Senior Vice President, Corporate Strategic Development
    11. Questcor to Report Fourth Quarter and Full Year 2012 Financial Results on February 26, 2013
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/3/2015)... LOS ANGELES , March 3, 2015 ... that Andrew Gengos , Chief Executive Officer of ... at the 27 th Annual ROTH Conference on ... the Ritz-Carlton Hotel, Laguna Niguel , ... webcast of the ROTH presentation, please log on through ...
    (Date:3/3/2015)... YORK , March 3, 2015  Immune Pharmaceuticals ... announced today that Dr. Daniel Teper , Chief ... on Wednesday, March 11, 2015 at 12:30 pm local ... The presentation will be webcast. ... About Immune Pharmaceuticals Inc. ...
    (Date:3/2/2015)... Ill. , March 2, 2015 Cure SMA ... California Institute of Biomedical Research (CALIBR). This funding is an ... in 2012, with a $700,000 Cure SMA grant to Dr. ... drug discovery program, "Optimization of Small Molecules that Increase ... Survival motor neuron (SMN) protein is critical to ...
    Breaking Medicine Technology:ImmunoCellular Therapeutics to Present at ROTH Conference on March 10th 2Immune Pharmaceuticals To Present At The Roth Conference 2Immune Pharmaceuticals To Present At The Roth Conference 3Cure SMA Announces $315,000 Grant to California Institute of Biomedical Research 2Cure SMA Announces $315,000 Grant to California Institute of Biomedical Research 3
    ... 2011 Hospira, Inc. (NYSE: HSP ), a ... that the company will present at the Sanford C. Bernstein ... in New York. The presentation is scheduled to ... 2011.  It will be available to all interested parties through ...
    ... May 12, 2011 Men and women infected with ... their sexual partners through initiation of oral antiretroviral therapy ... study conducted by the HIV Prevention Trials Network (HPTN), ... HIV through cutting-edge biomedical, behavioral, and structural interventions. ...
    Cached Medicine Technology:Initiation of Antiretroviral Treatment Protects Uninfected Sexual Partners from HIV Infection (HPTN Study 052) 2Initiation of Antiretroviral Treatment Protects Uninfected Sexual Partners from HIV Infection (HPTN Study 052) 3Initiation of Antiretroviral Treatment Protects Uninfected Sexual Partners from HIV Infection (HPTN Study 052) 4Initiation of Antiretroviral Treatment Protects Uninfected Sexual Partners from HIV Infection (HPTN Study 052) 5
    (Date:3/3/2015)... March 03, 2015 After the holiday ... lifestyle of fitness and exercise. Community Health Center of ... presenting 6 ways that families in Everett, Marysville, and ... winter months. , CHC says, “While it’s relatively ... and steamed veggies, many families wonder how to keep ...
    (Date:3/3/2015)... 2015 The Forbes Living ... great ideas when planning an Eco-vacation. It will review ... friendly approach. The segment will explore the greenest ground ... resort’s sustainability policy, request Earth-friendly choices along the way, ... about how to save electricity while away. More people ...
    (Date:3/3/2015)... 03, 2015 Sponsors of Medicare Advantage ... abundance of significant proposed changes to sift through as ... 2016 Call Letter released Feb. 20. The potential pay ... vary considerably with the type and location of the ... and comment on them before CMS issues the final ...
    (Date:3/3/2015)... Dr. Stephen Edgerton, a Cosmetic ... achieved Accredited Member Status in the American Academy ... accomplishment after completing a rigorous credentialing process including ... submission of clinical cases for examination. , ... in Connecticut, Charlotte, North Carolina, Caracas, Venezuela and ...
    (Date:3/3/2015)... Lake City, UT (PRWEB) March 03, 2015 ... is an innovative, user-friendly website that focuses on ... therapy, therapeutic boarding schools, and addiction treatment for ... Additionally, all residential interventions on the site have ... anxiety, ADHD, autism spectrum disorders, severe learning disabilities, ...
    Breaking Medicine News(10 mins):Health News:6 Wintertime Weight Loss Tips for Family Fitness Presented by Community Health Center of Snohomish County in Recent Article 2Health News:Forbes Living Segment on Planning an Eco-Vacation in the Works 2Health News:March 12 Webinar to Analyze Implications of CMS’s ’45-Day Notice’ and 2016 Call Letter for MA and Part D Plans 2Health News:Dr. Edgerton, a Dentist in Wilmington, NC, Achieves Accredited Status in AACD 2Health News:All Kinds of Therapy – New Website for Behavioral Health and Substance Abuse Treatment Launches Today 2
    ... Get Fit, Get,Right (http://www.getfitgetright.org ), an online ... type 2 diabetes and weight-related conditions,such as blindness, ... Fit, Get Right participants learn to adopt healthier ... they work to improve their,eating and exercise habits ...
    ... Performed ... Spinal Surgeries, AUSTIN, Texas, ... developing state-of-the-art, minimally invasive,surgical products, announced today at the North American ... use in some of,the most common spinal surgeries. The MD ...
    ... Conference Call for October 24th, 2007 at 5:00 p.m. ... (Nasdaq:,NUVA), a medical device company focused on developing products ... it,has cancelled the planned investor event scheduled for October ... Texas so that its CEO can return to,corporate headquarters ...
    ... WASHINGTON -- Cancer therapies save and prolong many lives, ... exact a debilitating toll on patients, mental and emotional ... with during oncology treatment. Cancer care that focuses ... well-being can increase patients, suffering, may compromise their ability ...
    ... University researchers to help train people to change their ... now been shown to reduce the production of the ... October issue of the American Psychological Associations Journal of ... it was possible to design games to allow people ...
    ... (Nasdaq: MDRX ),the leading provider of clinical ... improve healthcare, announced today that,it will report its ... September,30, 2007 after the stock market closes on ... Time on the same day, Allscripts management will,host ...
    Cached Medicine News:Health News:MultiVu Video Feed: STARLIGHT STARBRIGHT UNVEILS GET FIT, GET RIGHT A PROGRAM TO PREVENT TYPE 2 DIABETES AND WEIGHT-RELATED CONDITIONS IN TEENS 2Health News:ArthroCare Releases New SpineWand(R) for Less Invasive Spinal Surgeries 2Health News:ArthroCare Releases New SpineWand(R) for Less Invasive Spinal Surgeries 3Health News:NuVasive Cancels 10/24/07 Investor Reception Due to Concerns Over Southern California Fires 2Health News:NuVasive Cancels 10/24/07 Investor Reception Due to Concerns Over Southern California Fires 3Health News:NuVasive Cancels 10/24/07 Investor Reception Due to Concerns Over Southern California Fires 4Health News:Cancer care providers need to proactively address patients' psychological and social needs 2Health News:Cancer care providers need to proactively address patients' psychological and social needs 3Health News:Video game shown to cut cortisol 2Health News:Allscripts to Announce Third Quarter 2007 Results on November 8th 2Health News:Allscripts to Announce Third Quarter 2007 Results on November 8th 3
    ... UltraFix MiniMite Suture Anchor System ... the market that will accept ... surface until deployed eliminates tissue, ... its ultra smooth eyelet hole ...
    ... The R-F10 simplifies the ... unprecedented degree - all operations ... a press of the Start ... the entire series of steps ...
    ... imaging have become more acute. The ... radiation exposure to both patient and staff ... and Bi-Plane systems. In keeping with ... in price/value relationship, four bi-plane imaging configurations ...
    ... HARMONY Cardiology Module incorporates an integrated ... Open Systems Technology mandated by the ... Allowing for easy access to hospital ... HARMONY provides new efficiency with electronic ...
    Medicine Products: